Search Results - "Duignan, D B"
-
1
Understanding the clinical pharmacokinetics of a GABAA partial agonist by application of in vitro tools
Published in Xenobiotica (01-07-2010)“…4-Oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxylic acid (4-methylaminomethyl-phenyl)-amide (1), developed for general anxiety disorder, was discontinued from…”
Get full text
Journal Article -
2
Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450
Published in Drug metabolism and disposition (01-11-1987)“…Chloramphenicol (CAP) is a potent and effective mechanism-based inactivator of the major phenobarbital (PB)-inducible isozyme of dog liver cytochrome P-450…”
Get more information
Journal Article -
3
Purification and characterization of the dog hepatic cytochrome P-450 isozyme responsible for the metabolism of 2,2',4,4',5,5'-hexachlorobiphenyl
Published in Archives of biochemistry and biophysics (01-06-1987)“…The biochemical basis for the marked difference in the rate of the hepatic metabolism of 2,2',4,4',5,5'-hexachlorobiphenyl (245-HCB) by Beagle dogs and…”
Get more information
Journal Article -
4
The metabolism of xenobiotics and endogenous compounds by the constitutive dog liver cytochrome P450 PBD-2
Published in Archives of biochemistry and biophysics (15-11-1988)“…We have investigated the metabolism of polychlorinated biphenyls and endogenous steroids by the major phenobarbital (PB)-inducible hepatic cytochromes P450 in…”
Get more information
Journal Article -
5
Synthesis, sar and pharmacology of CP-293,019 : A potent, selective dopamine D4 receptor antagonist
Published in Bioorganic & medicinal chemistry letters (07-04-1998)“…A series of novel, potent and selective pyrido[1,2-a]pyrazine dopamine D4 receptor antagonists are reported including CP-293,019 (D4 Ki = 3.4 nM, D2 Ki > 3,310…”
Get full text
Journal Article -
6
Expression and Characterization of Canine Cytochrome P450 2D15
Published in Archives of biochemistry and biophysics (01-09-1998)“…CYP2D15 is the canine ortholog of human CYP2D6, the human CYP2D isoform involved in the metabolism of drugs such as antiarhythmics, adrenoceptor antagonists,…”
Get full text
Journal Article -
7
Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats
Published in The Journal of pharmacology and experimental therapeutics (01-10-2016)“…Inhibition of the sphingosine-1-phosphate (S1P)-catabolizing enzyme S1P lyase (S1PL) elevates the native ligand of S1P receptors and provides an alternative…”
Get more information
Journal Article -
8
Understanding the clinical pharmacokinetics of a GABA A partial agonist by application of in vitro tools
Published in Xenobiotica (01-07-2010)Get full text
Journal Article -
9
A 96-Well Efflux Assay To Identify ABCG2 Substrates Using a Stably Transfected MDCK II Cell Line
Published in Molecular pharmaceutics (01-01-2006)“…Human ABCG2 (breast cancer resistance protein, BCRP) is an important efflux transporter which exhibits broad substrate specificity and which is found in many…”
Get full text
Journal Article -
10
Synthesis, sar and pharmacology of CP-293,019: A potent, selective dopamine D 4 receptor antagonist
Published in Bioorganic & medicinal chemistry letters (07-04-1998)“…A series of novel, potent and selective pyrido[1,2- a]pyrazine dopamine D 4 receptor antagonists are reported including CP-293,019 (D 4 K i = 3.4 nM, D 2 K i >…”
Get full text
Journal Article